Ionis Pharmaceuticals Surges Into Buy Zone As It, Possibly, Proves Biogen Wrong
Investor's Business DailyIonis Pharmaceuticals stock surged Monday after the company unveiled promising results for a drug that treats a rare genetic condition.
The post Ionis Pharmaceuticals Surges Into Buy Zone As It, Possibly, Proves Biogen Wrong appeared first on Investor&…